EXPLORING HEALTHCARE MEDICATION-SKILLS, PROFESSIONALISM AND OPPORTUNITIES OF PHARMACY-BASED HEALTHCARE PROVIDERS IN MALAYSIA

Background: Through qualitative and quantitative methods, this study will contribute to a deeper understanding of the evolving role of pharmacy-based healthcare providers in Malaysia and highlight strategies to optimize their impact within the healthcare framework. The evolving landscape of healthcare in Malaysia has placed increasing emphasis on the role of pharmacy-based healthcare providers in delivering patient-centered care. As healthcare systems worldwide shift toward more integrated approaches, pharmacists are uniquely positioned to contribute through their expertise in medication management and patient education. This study explores the current state of medication skills, professionalism, and the opportunities available for pharmacists in Malaysia. Objective: This study investigates the knowledge, professionalism, and perceptions of pharmacy-based healthcare providers among students at University College MAIWP International (UCMI) in Malaysia. Method: A total of 341 students participated in a survey assessing their understanding of pharmacists' roles, responsibilities, and contributions to healthcare. Results: The findings indicate a strong recognition of pharmacists' importance in medication management and patient care, with 93.5% acknowledging their role in helping manage medications effectively. Despite a consensus on the necessity for higher education in pharmacy, 89.2% of respondents believed a high school diploma suffices to become a pharmacy practitioner. Additionally, both male and female students demonstrated similar levels of awareness regarding the diverse responsibilities of pharmacists beyond traditional roles. Conclusions: The study highlights the need for greater integration of pharmacy professionals into the healthcare system and calls for enhanced educational initiatives to elevate the understanding of pharmacy roles among the general public and healthcare providers. Peer Review History: Received 21 July 2024; Reviewed 13 September 2024; Accepted 25 October; Available online 15 November 2024 Academic Editor: Dr. Emmanuel O. Olorunsola, Department of Pharmaceutics & Pharmaceutical Technology, University of Uyo, Nigeria, [email protected] Average Peer review marks at initial stage: 6.0/10 Average Peer review marks at publication stage: 7.0/10 Reviewers: Dr. Rima Benatoui, Applied Neuroendocrinology Laboratory, Faculty of Sciences, University of Annaba, Algeria. [email protected] Sheima Nadim Kadhim, Deparment of Pharmacology and Toxicology, College of pharmacy, University of Basra, Iraq. [email protected]